Qnexa: Clinical Trials

3 trials of Qnexa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Qnexa: new trials by email Literature Review of Qnexa trials Research Report on Qnexa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy
Topiramate, Placebo administration - PTSD, Alcohol Abuse
Phase 4CompletedUniversity of California, San Francisco302010-04-012014-06-03
A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
VI-0521, Placebo - Obesity
Phase 3CompletedVIVUS LLC6762008-12-012012-09-10
A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults
VI-0521, placebo - Sleep Apnea
Phase 1 / Phase 2CompletedVIVUS LLC452008-08-012012-10-05

Conditions studied

Obesity (2)  ·  Alcoholism (1)  ·  Sleep Apnea Syndromes (1)  ·  Stress Disorders, Post-Traumatic (1)

Sponsors

VIVUS LLC (2)  ·  University of California, San Francisco (1)

Countries

United States (2)

Top investigators

Charles Bowden, MD (1)  ·  Craig Peterson (1)  ·  Steven L. Batki, MD (1)

Results publications

PMID 22158731, PMID 28455281